UMPJE 2026: Controlled Substance Scheduling & DEA Registration

Описание: Who can touch the "Closed System"? In 2026, DEA registration isn't just a certificate—it's a series of mandatory federal obligations. In Video 12, we break down Controlled Substance Scheduling and DEA Registration under the new 2026 UMPJE blueprint.

As the Uniform MPJE (UMPJE) launches, Domain 3 (Regulatory Authority) tests your understanding of federal jurisdiction. Today, we cover the high-stakes "Closed System of Distribution" and the specific requirements for different types of registrants.

What we cover today:

The 2026 Telemedicine Bridge: How the DEA's extension through Dec 31, 2026, impacts registration requirements for remote prescribers.

The MATE Act (8-Hour Rule): The one-time federal training requirement for all practitioners (except veterinarians) and how to attest during renewal.

Scheduling Criteria: The 8 factors used to determine if a drug is C-I through C-V (Abuse potential vs. medical use).

DEA Registration Types: Breaking down Form 224 (Pharmacy) vs. Form 225 (Manufacturer) vs. Form 363 (Narcotic Treatment Programs).

The 3-Year Renewal Cycle: Deadlines, registration fees ($888 for 3 years), and the "Grace Period" trap.

The Closed System: Why every transfer of a controlled substance must occur between DEA registrants.


🎓 Watch the Full UMPJE Masterclass Playlist: [   • Плейлист  ]
🔔 Subscribe for the latest 2026 Federal Pharmacy Law updates!

Keywords
UMPJE 2026, Uniform MPJE, DEA Registration, Controlled Substance Scheduling, MATE Act 2026, DEA Form 224, Telemedicine Extension 2026, Federal Pharmacy Law, CSA Schedule I-V, Pharmacy Law Domain 3, NABP Blueprint 2026, Mid-Level Practitioner DEA, DEA Renewal Deadline.

#UMPJE2026 #PharmacyLaw #DEA #MATEAct #Pharmacist #PharmacyStudent #Domain3 #ControlledSubstances #MPJEPrep #HealthcareLaw